{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:13:24Z","timestamp":1788243204488,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11892-025-01599-x","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T06:38:49Z","timestamp":1753079929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare"],"prefix":"10.1007","volume":"25","author":[{"given":"Lakshmi","family":"Nagendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjan","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saptarshi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishka","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B. M.","family":"Kamrul-Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"2","key":"1599_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00223-016-0175-x","volume":"100","author":"J Starup-Linde","year":"2017","unstructured":"Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B. Epidemiology of fractures in diabetes. Calcif Tissue Int. 2017;100(2):109\u201321.","journal-title":"Calcif Tissue Int"},{"issue":"13","key":"1599_CR2","doi-asserted-by":"publisher","first-page":"1052592","DOI":"10.3389\/fendo.2022.1052592","volume":"14","author":"B Wu","year":"2022","unstructured":"Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y, et al. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Front Endocrinol. 2022;14(13):1052592.","journal-title":"Front Endocrinol"},{"issue":"3","key":"1599_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4239\/wjd.v2.i3.41","volume":"2","author":"K Wongdee","year":"2011","unstructured":"Wongdee K, Charoenphandhu N. Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J Diabetes. 2011;2(3):41\u20138.","journal-title":"World J Diabetes"},{"issue":"1","key":"1599_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11657-024-01399-y","volume":"19","author":"M Chandran","year":"2024","unstructured":"Chandran M, Aftab N, Amin A, Amphansap T, Bhadada SK, Chadha M, et al. Evaluating compliance with the care standard of proactively assessing bone health in patients with diabetes: a pilot audit of practice across Asia by the Asia Pacific Consortium on Osteoporosis (APCO). Arch Osteoporos. 2024;19(1):48.","journal-title":"Arch Osteoporos"},{"issue":"12","key":"1599_CR5","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","volume":"29","author":"SL Ferrari","year":"2018","unstructured":"Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018;29(12):2585\u201396.","journal-title":"Osteoporos Int"},{"key":"1599_CR6","unstructured":"Burden of Osteoporosis | International Osteoporosis Foundation [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.osteoporosis.foundation\/policy-makers\/burden-osteoporosis"},{"key":"1599_CR7","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","volume":"137","author":"T Vilaca","year":"2020","unstructured":"Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, et al. The risk of hip and nonvertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. Bone. 2020;137:115457.","journal-title":"Bone"},{"issue":"6","key":"1599_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/dc12-1355","volume":"36","author":"VV Zhukouskaya","year":"2013","unstructured":"Zhukouskaya VV, Eller-Vainicher C, Vadzianava VV, Shepelkevich AP, Zhurava IV, Korolenko GG, et al. Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care. 2013;36(6):1635\u201340.","journal-title":"Diabetes Care"},{"issue":"5","key":"1599_CR9","doi-asserted-by":"publisher","first-page":"e1860","DOI":"10.1210\/clinem\/dgac031","volume":"107","author":"JC Coll","year":"2022","unstructured":"Coll JC, Garceau \u00c9, Leslie WD, Genest M, Michou L, Weisnagel SJ, et al. Prevalence of vertebral fractures in adults with type 1 diabetes: DenSiFy study (Diabetes Spine Fractures). J Clin Endocrinol Metab. 2022;107(5):e1860\u201370.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1599_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2337\/dc19-0925","volume":"43","author":"F Koromani","year":"2020","unstructured":"Koromani F, Oei L, Shevroja E, Trajanoska K, Schoufour J, Muka T, et al. Vertebral fractures in individuals with type 2 diabetes: More than skeletal complications alone. Diabetes Care. 2020;43(1):137\u201344.","journal-title":"Diabetes Care"},{"issue":"10","key":"1599_CR11","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/obr.12885","volume":"20","author":"K Hidayat","year":"2019","unstructured":"Hidayat K, Du X, Wu MJ, Shi BM. The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies. Obes Rev Off J Int Assoc Study Obes. 2019;20(10):1494\u2013503.","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"issue":"2","key":"1599_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00223-016-0203-x","volume":"100","author":"M Chandran","year":"2017","unstructured":"Chandran M. Diabetes drug effects on the skeleton. Calcif Tissue Int. 2017;100(2):133\u201349.","journal-title":"Calcif Tissue Int"},{"key":"1599_CR13","first-page":"17","volume":"9","author":"S Pscherer","year":"2016","unstructured":"Pscherer S, Kostev K, Dippel FW, Rathmann W. Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care. Diabetes Metab Syndr Obes Targets Ther. 2016;9:17\u201323.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"1","key":"1599_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12891-023-06493-9","volume":"24","author":"M Bahardoust","year":"2023","unstructured":"Bahardoust M, Yarali M, Donyadideh G, Rahimi E, Naderi D, Tehrani FM, et al. The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies. BMC Musculoskelet Disord. 2023;24(1):367.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"1599_CR15","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.pharep.2017.05.008","volume":"69","author":"M Adil","year":"2017","unstructured":"Adil M, Khan RA, Kalam A, Venkata SK, Kandhare AD, Ghosh P, et al. Effect of antidiabetic drugs on bone metabolism: Evidence from preclinical and clinical studies. Pharmacol Rep PR. 2017;69(6):1328\u201340.","journal-title":"Pharmacol Rep PR"},{"key":"1599_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","volume":"68","author":"ZN Zhu","year":"2014","unstructured":"Zhu ZN, Jiang YF, Ding T. Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. Bone. 2014;68:115\u201323.","journal-title":"Bone"},{"issue":"3","key":"1599_CR17","first-page":"914","volume":"102","author":"CM Viscoli","year":"2017","unstructured":"Viscoli CM, Inzucchi SE, Young LH, Insogna KL, Conwit R, Furie KL, et al. Pioglitazone and Risk for Bone fracture: Safety data from a randomized clinical trial. J Clin Endocrinol Metab. 2017;102(3):914\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1599_CR18","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1530\/JOE-17-0278","volume":"236","author":"G Mabilleau","year":"2018","unstructured":"Mabilleau G, Pereira M, Chenu C. Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists. J Endocrinol. 2018;236(1):R29-42.","journal-title":"J Endocrinol"},{"issue":"4","key":"1599_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MED.0000000000000813","volume":"30","author":"J Starup-Linde","year":"2023","unstructured":"Starup-Linde J, Hygum K, Langdahl B. Effect of incretins on skeletal health. Curr Opin Endocrinol Diabetes Obes. 2023;30(4):206\u201312.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"1599_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1210\/jc.2015-1860","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, et al. Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin. J Clin Endocrinol Metab. 2016;101(1):44\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1599_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644\u201357.","journal-title":"N Engl J Med"},{"issue":"4","key":"1599_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347\u201357.","journal-title":"N Engl J Med"},{"issue":"11","key":"1599_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMc1600827","volume":"374","author":"PA Sarafidis","year":"2016","unstructured":"Sarafidis PA, Tsapas A. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2016;374(11):1092.","journal-title":"N Engl J Med"},{"issue":"1","key":"1599_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12902-024-01575-8","volume":"24","author":"J Wang","year":"2024","unstructured":"Wang J, Li X, Li Y, Lei C. Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMC Endocr Disord. 2024;24(1):52.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"1599_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.diabet.2019.01.010","volume":"45","author":"L Cheng","year":"2019","unstructured":"Cheng L, Li YY, Hu W, Bai F, Hao HR, Yu WN, et al. Risk of bone fracture associated with sodium-glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials. Diabetes Metab. 2019;45(5):436\u201345.","journal-title":"Diabetes Metab"},{"issue":"12","key":"1599_CR26","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/dom.12742","volume":"18","author":"HL Tang","year":"2016","unstructured":"Tang HL, Li DD, Zhang JJ, Hsu YH, Wang TS, Zhai SD, et al. Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2016;18(12):1199\u2013206.","journal-title":"Diabetes Obes Metab"},{"key":"1599_CR27","doi-asserted-by":"crossref","unstructured":"M Z, Ce H, Jm P, Lg B, Dj W, Dh K, et al. Association of sodium-glucose cotransporter-2 inhibitors with fracture risk in older adults with type 2 diabetes. JAMA Netw Open [Internet]. 2021 Oct 1 [cited 2025 Jan 29];4(10). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34705014\/","DOI":"10.1001\/jamanetworkopen.2021.30762"},{"issue":"2","key":"1599_CR28","doi-asserted-by":"publisher","first-page":"e3780","DOI":"10.1002\/dmrr.3780","volume":"40","author":"Y Shen","year":"2024","unstructured":"Shen Y, Shi Q, Zou X, Meng W, Tian H, Du L, et al. Time-dependent risk of fracture in adults with type 2 diabetes receiving antidiabetic drug: A one-stage network meta-analysis. Diabetes Metab Res Rev. 2024;40(2):e3780.","journal-title":"Diabetes Metab Res Rev"},{"key":"1599_CR29","doi-asserted-by":"publisher","first-page":"918350","DOI":"10.3389\/fendo.2022.918350","volume":"13","author":"B Dong","year":"2022","unstructured":"Dong B, Lv R, Wang J, Che L, Wang Z, Huai Z, et al. The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture. Front Endocrinol. 2022;13:918350.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1599_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2967\/jnumed.120.256180","volume":"62","author":"KN Haseltine","year":"2021","unstructured":"Haseltine KN, Chukir T, Smith PJ, Jacob JT, Bilezikian JP, Farooki A. Bone mineral density: clinical relevance and quantitative assessment. J Nucl Med. 2021;62(4):446\u201354.","journal-title":"J Nucl Med"},{"issue":"45","key":"1599_CR31","doi-asserted-by":"publisher","first-page":"e40468","DOI":"10.1097\/MD.0000000000040468","volume":"103","author":"M Li","year":"2024","unstructured":"Li M, Sun H, Chen H, Ma W, Li Y. Type 2 diabetes and bone mineral density: A meta-analysis and systematic review. Medicine (Baltimore). 2024;103(45):e40468.","journal-title":"Medicine (Baltimore)"},{"issue":"21","key":"1599_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12902-021-00815-5","volume":"6","author":"SC Bilha","year":"2021","unstructured":"Bilha SC, Leustean L, Preda C, Branisteanu DD, Mihalache L, Ungureanu MC. Bone mineral density predictors in long-standing type 1 and type 2 diabetes mellitus. BMC Endocr Disord. 2021;6(21):156.","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"1599_CR33","first-page":"716","volume":"22","author":"M Chandran","year":"2016","unstructured":"Chandran M, Tay D, Tan M, Hao Y, Huang XF, Khoo J, et al. Axial BMD in diabetic and nondiabetic southeast asians with hip fractures: Do race and body mass index matter? Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2016;22(6):716\u201325.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"1599_CR34","unstructured":"American Diabetes Association Professional Practice Committee. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes\u20142025. Diabetes Care. 2024;48(Supplement_1):S59\u201385."},{"issue":"3","key":"1599_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res Off J Am Soc Bone Miner Res. 2014;29(3):518\u201330.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"5","key":"1599_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40520-016-0634-2","volume":"29","author":"G Bonaccorsi","year":"2017","unstructured":"Bonaccorsi G, Fila E, Messina C, Maietti E, Ulivieri FM, Caudarella R, et al. Comparison of trabecular bone score and hip structural analysis with FRAX\u00ae in postmenopausal women with type 2 diabetes mellitus. Aging Clin Exp Res. 2017;29(5):951\u20137.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"1599_CR37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1210\/jc.2012-3118","volume":"98","author":"WD Leslie","year":"2013","unstructured":"Leslie WD, Aubry-Rozier B, Lamy O, Hans D, Manitoba Bone Density Program. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab. 2013;98(2):602\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"1599_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00223-017-0330-z","volume":"102","author":"KL Holloway","year":"2018","unstructured":"Holloway KL, De Abreu LLF, Hans D, Kotowicz MA, Sajjad MA, Hyde NK, et al. Trabecular bone score in men and women with impaired fasting glucose and diabetes. Calcif Tissue Int. 2018;102(1):32\u201340.","journal-title":"Calcif Tissue Int"},{"key":"1599_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bone.2017.08.007","volume":"105","author":"M Iki","year":"2017","unstructured":"Iki M, Fujita Y, Kouda K, Yura A, Tachiki T, Tamaki J, et al. Hyperglycemia is associated with increased bone mineral density and decreased trabecular bone score in elderly Japanese men: The Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Bone. 2017;105:18\u201325.","journal-title":"Bone"},{"issue":"2","key":"1599_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1210\/jc.2014-2047","volume":"100","author":"JH Kim","year":"2015","unstructured":"Kim JH, Choi HJ, Ku EJ, Kim KM, Kim SW, Cho NH, et al. Trabecular bone score as an indicator for skeletal deterioration in diabetes. J Clin Endocrinol Metab. 2015;100(2):475\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1599_CR41","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00198-019-05053-z","volume":"30","author":"LT Ho-Pham","year":"2019","unstructured":"Ho-Pham LT, Nguyen TV. Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2019;30(10):2079\u201385.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"5","key":"1599_CR42","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00198-012-2147-y","volume":"24","author":"HC van der Jagt-Willems","year":"2013","unstructured":"van der Jagt-Willems HC, Vis M, Tulner CR, van Campen JPCM, Woolf AD, van Munster BC, et al. Mortality and incident vertebral fractures after 3 years of follow-up among geriatric patients. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2013;24(5):1713\u20139.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"1599_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jocd.2007.12.008","volume":"11","author":"JT Schousboe","year":"2008","unstructured":"Schousboe JT, Vokes T, Broy SB, Ferrar L, McKiernan F, Roux C, et al. Vertebral Fracture Assessment: the 2007 ISCD Official Positions. J Clin Densitom Off J Int Soc Clin Densitom. 2008;11(1):92\u2013108.","journal-title":"J Clin Densitom Off J Int Soc Clin Densitom"},{"issue":"3","key":"1599_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","volume":"47","author":"M Schini","year":"2024","unstructured":"Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest. 2024;47(3):501\u201311.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1599_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11657-021-00931-8","volume":"16","author":"L Nagendra","year":"2021","unstructured":"Nagendra L, Bhavani N, Menon VU, Pavithran PV, Menon AS, Abraham N, et al. FRAX-based osteoporosis treatment guidelines for resource-poor settings in India. Arch Osteoporos. 2021;16(1):69.","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1599_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00198-024-07328-6","volume":"36","author":"L Nagendra","year":"2025","unstructured":"Nagendra L, Chandran M, Reginster JY, Bhadada SK, Bhattacharya S, Dutta D, et al. Cost-effectiveness of FRAX\u00ae-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2025;36(2):311\u201322.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"4","key":"1599_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jbmr\/zjaf012","volume":"40","author":"RK Jain","year":"2025","unstructured":"Jain RK, Liu JY, Grant RW, Haider S, Huang ES, Laiteerapong N, et al. Biases in the performance of FRAX without BMD in predicting fracture risk in a multiethnic population with diabetes: the Diabetes and aging study. J Bone Miner Res Off J Am Soc Bone Miner Res. 2025;40(4):478\u201391.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"11","key":"1599_CR48","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/jbmr.3538","volume":"33","author":"WD Leslie","year":"2018","unstructured":"Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D. Comparison of methods for improving fracture risk assessment in diabetes: The manitoba BMD registry. J Bone Miner Res Off J Am Soc Bone Miner Res. 2018;33(11):1923\u201330.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"1599_CR49","unstructured":"FRAX plus | FRAXplus\u00ae [Internet]. [cited 2025 Jan 30]. Available from: https:\/\/www.fraxplus.org\/frax-plus"},{"issue":"10","key":"1599_CR50","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, et al. The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2022;33(10):2049\u2013102.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"1599_CR51","doi-asserted-by":"publisher","first-page":"100796","DOI":"10.1016\/j.ijotn.2020.100796","volume":"39","author":"DS Anupama","year":"2020","unstructured":"Anupama DS, Norohna JA, Acharya KK, George A. Effect of exercise on bone mineral density and quality of life among postmenopausal women with osteoporosis without fracture: A systematic review. Int J Orthop Trauma Nurs. 2020;39:100796.","journal-title":"Int J Orthop Trauma Nurs"},{"issue":"2","key":"1599_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00198-024-07307-x","volume":"36","author":"P Bajaj","year":"2025","unstructured":"Bajaj P, Nagendra L, Bajaj A, Samuel M, Chandran M. Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2025;36(2):193\u2013224.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"6","key":"1599_CR53","doi-asserted-by":"publisher","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","volume":"7","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, S\u00f8rensen V, Sandsdal RM, Lehmann EW, Lundgren JR, Juhl CR, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment. JAMA Netw Open. 2024;7(6):e2416775.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1599_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MED.0000000000000645","volume":"28","author":"M Shah","year":"2021","unstructured":"Shah M, Appuswamy AV, Rao SD, Dhaliwal R. Treatment of bone fragility in patients with diabetes: Antiresorptive versus anabolic? Curr Opin Endocrinol Diabetes Obes. 2021;28(4):377\u201382.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"11","key":"1599_CR55","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/jbmr.4697","volume":"37","author":"R Eastell","year":"2022","unstructured":"Eastell R, Vittinghoff E, Lui LY, Ewing SK, Schwartz AV, Bauer DC, et al. Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk. J Bone Miner Res Off J Am Soc Bone Miner Res. 2022;37(11):2121\u201331.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"1599_CR56","doi-asserted-by":"publisher","first-page":"115268","DOI":"10.1016\/j.bone.2020.115268","volume":"134","author":"S Ferrari","year":"2020","unstructured":"Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A, et al. Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension. Bone. 2020;134:115268.","journal-title":"Bone"},{"issue":"381","key":"1599_CR57","doi-asserted-by":"publisher","first-page":"e073435","DOI":"10.1136\/bmj-2022-073435","volume":"18","author":"H Lyu","year":"2023","unstructured":"Lyu H, Zhao SS, Zhang L, Wei J, Li X, Li H, et al. Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study. BMJ. 2023;18(381):e073435.","journal-title":"BMJ"},{"key":"1599_CR58","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","volume":"91","author":"AV Schwartz","year":"2016","unstructured":"Schwartz AV, Pavo I, Alam J, Disch DP, Schuster D, Harris JM, et al. Teriparatide in patients with osteoporosis and type 2 diabetes. Bone. 2016;91:152\u20138.","journal-title":"Bone"},{"issue":"4","key":"1599_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10346","volume":"4","author":"R Dhaliwal","year":"2020","unstructured":"Dhaliwal R, Hans D, Hattersley G, Mitlak B, Fitzpatrick LA, Wang Y, et al. Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: A post Hoc analysis of the ACTIVE study. JBMR Plus. 2020;4(4): e10346.","journal-title":"JBMR Plus"},{"issue":"3","key":"1599_CR60","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"Hygum K, Starup-Linde J, Harsl\u00f8f T, Vestergaard P, Langdahl BL. Mechanisms in endocrinology: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137\u201357.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1599_CR61","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/jcm10081660","volume":"10","author":"A VestergaardKvist","year":"2021","unstructured":"VestergaardKvist A, Faruque J, Vallejo-Yag\u00fce E, Weiler S, Winter EM, Burden AM. Cardiovascular safety profile of romosozumab: A pharmacovigilance analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS). J Clin Med. 2021;10(8):1660.","journal-title":"J Clin Med"},{"issue":"2","key":"1599_CR62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00198-022-06622-5","volume":"34","author":"AR Agarwal","year":"2023","unstructured":"Agarwal AR, Cohen JS, Jorgensen A, Thakkar SC, Srikumaran U, Golladay GJ. Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2023;34(2):379\u201385.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"1599_CR63","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/jep.13164","volume":"26","author":"P Thakur","year":"2020","unstructured":"Thakur P, Kuriakose C, Cherian KE, Asha HS, Kapoor N, Paul TV. Knowledge gap regarding osteoporosis among medical professionals in Southern India. J Eval Clin Pract. 2020;26(1):272\u201380.","journal-title":"J Eval Clin Pract"},{"issue":"3 Suppl","key":"1599_CR64","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1097\/OI9.0000000000000192","volume":"5","author":"SL Kates","year":"2022","unstructured":"Kates SL, Miclau T. The fracture liaison service: its history, current state, how it works, and future directions. OTA Int. 2022;5(3 Suppl):e192.","journal-title":"OTA Int"},{"issue":"8","key":"1599_CR65","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K \u00c5kesson","year":"2013","unstructured":"\u00c5kesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, et al. Capture the fracture: A best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013;24(8):2135\u201352.","journal-title":"Osteoporos Int"},{"issue":"6","key":"1599_CR66","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00198-018-4411-2","volume":"29","author":"CH Wu","year":"2018","unstructured":"Wu CH, Kao IJ, Hung WC, Lin SC, Liu HC, Hsieh MH, et al. Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2018;29(6):1227\u201342.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"3","key":"1599_CR67","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00198-015-3443-0","volume":"27","author":"A Nakayama","year":"2016","unstructured":"Nakayama A, Major G, Holliday E, Attia J, Bogduk N. Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2016;27(3):873\u20139.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"5","key":"1599_CR68","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00198-016-3894-y","volume":"28","author":"NCW Harvey","year":"2017","unstructured":"Harvey NCW, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster JY, et al. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2017;28(5):1507\u201329.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"1599_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.afos.2016.11.004","volume":"3","author":"VH Nguyen","year":"2017","unstructured":"Nguyen VH. Osteoporosis prevention and osteoporosis exercise in community-based public health programs. Osteoporos Sarcopenia. 2017;3(1):18\u201331.","journal-title":"Osteoporos Sarcopenia"},{"issue":"112","key":"1599_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.maturitas.2018.04.003","volume":"1","author":"RA Scott","year":"2018","unstructured":"Scott RA, Callisaya ML, Duque G, Ebeling PR, Scott D. Assistive technologies to overcome sarcopenia in ageing. Maturitas. 2018;1(112):78\u201384.","journal-title":"Maturitas"},{"issue":"6","key":"1599_CR71","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40271-024-00714-6","volume":"17","author":"EL Hinzpeter","year":"2024","unstructured":"Hinzpeter EL, Nagendra L, Kairies-Schwarz N, Beaudart C, Hiligsmann M. Stated preferences of at-risk populations for the treatment of osteoporosis: A systematic review. The Patient. 2024;17(6):619\u201334.","journal-title":"The Patient"},{"key":"1599_CR72","unstructured":"Non communicable diseases [Internet]. [cited 2025 Apr 24]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases"},{"issue":"17","key":"1599_CR73","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.3390\/nu15173742","volume":"15","author":"PN Nyakundi","year":"2023","unstructured":"Nyakundi PN, N\u00e9methn\u00e9Kont\u00e1r Z, Kov\u00e1cs A, J\u00e1romi L, Zand A, Lohner S. Fortification of staple foods for household use with vitamin D: An overview of systematic reviews. Nutrients. 2023;15(17):3742.","journal-title":"Nutrients"},{"key":"1599_CR74","doi-asserted-by":"crossref","unstructured":"Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. Cost-Effectiveness Analysis. In: Priorities in Health [Internet]. The International Bank for Reconstruction and Development \/ The World Bank; 2006 [cited 2025 Apr 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK10253\/","DOI":"10.1596\/978-0-8213-6260-0\/Chpt-3"},{"key":"1599_CR75","unstructured":"Gupta L, Adizie T, Venerito V, Casteleyn C, Del Vescovo S, Jasim M, et al. Clinical Utility of Large Language Models for Osteoporosis Referral triage: A Pilot Study. RMD Open 2025. In press."},{"issue":"4","key":"1599_CR76","doi-asserted-by":"publisher","first-page":"e29744","DOI":"10.2196\/29744","volume":"4","author":"M Pech","year":"2021","unstructured":"Pech M, Sauzeon H, Yebda T, Benois-Pineau J, Amieva H. Falls detection and prevention systems in home care for older adults: Myth or reality? JMIR Aging. 2021;4(4):e29744.","journal-title":"JMIR Aging"},{"issue":"4","key":"1599_CR77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40674-022-00195-4","volume":"8","author":"JL Saag","year":"2022","unstructured":"Saag JL, Danila MI. Remote management of osteoporosis. Curr Treat Options Rheumatol. 2022;8(4):143\u201351.","journal-title":"Curr Treat Options Rheumatol"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-025-01599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-025-01599-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-025-01599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:03:15Z","timestamp":1770296595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-025-01599-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1007\/s11892-025-01599-x","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"10 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The views and opinions expressed are solely those of the authors and do not represent or reflect those of any affiliated institutions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"43"}}